Piflufolastat F 18 Enrolling by Invitation Phase 2 Trials for Neoplasms of the Prostate / Prostate Cancer / refractory, metastatic hormone-refractory Prostate cancer Diagnostic

IndicationsStatusPurposePhase
Enrolling by InvitationDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT0318186718F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer